Literature DB >> 26780150

How are neuroticism and depression related to the psychophysiological stress response to acute stress in healthy older people?

Sara Puig-Perez1, Carolina Villada2, Matias M Pulopulos2, Vanesa Hidalgo2, Alicia Salvador2.   

Abstract

Neuroticism and depressive symptomatology have been related to a heightened and diminished physiological stress response, which may partly explain their negative relationship with health and wellbeing. Identifying factors that may increase disease vulnerability is especially relevant in older people, whose physiological systems decline. With this in mind, we investigated the influence of neuroticism and depression on the psychophysiological stress response in healthy older people (from 55 to 76years old). A total of 36 volunteers were exposed to a stressful task (Trier Social Stress Test, TSST), while 35 volunteers performed a control non-stressful task. The physiological stress response was assessed through measures of cortisol, alpha-amylase, heart rate (HR). Our results showed that, neuroticism was not related to physiological stress response. However, depression was related to higher cortisol response and lower HR reactivity in the stress condition. In summary, emotional states such as depressive mood seem to amplify the cortisol stress response and reduce the cardiovascular response, whereas more stable dispositions such as neuroticism did not affect stress response in older people. These findings confirm, in healthy older people, the adverse effects of depression, acting on different subsystems of the stress response.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alpha-amylase; Cortisol; Depression; Neuroticism; Stress

Mesh:

Substances:

Year:  2016        PMID: 26780150     DOI: 10.1016/j.physbeh.2016.01.015

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress.

Authors:  Alexander Fiksdal; Luke Hanlin; Yuliya Kuras; Danielle Gianferante; Xuejie Chen; Myriam V Thoma; Nicolas Rohleder
Journal:  Psychoneuroendocrinology       Date:  2018-11-24       Impact factor: 4.905

2.  Neuroticism Magnifies the Detrimental Association between Social Media Addiction Symptoms and Wellbeing in Women, but Not in Men: a three-Way Moderation Model.

Authors:  Ofir Turel; Natalie Tasha Poppa; Oren Gil-Or
Journal:  Psychiatr Q       Date:  2018-09

3.  Stressful life events, relationship stressors, and cortisol reactivity: The moderating role of suppression.

Authors:  Lydia G Roos; Sara M Levens; Jeanette M Bennett
Journal:  Psychoneuroendocrinology       Date:  2018-01-02       Impact factor: 4.905

4.  Is stressor-evoked cardiovascular reactivity a pathway linking positive and negative emotionality to preclinical cardiovascular disease risk?

Authors:  Caitlin M DuPont; Aidan G C Wright; Stephen B Manuck; Matthew F Muldoon; J Richard Jennings; Peter J Gianaros
Journal:  Psychophysiology       Date:  2020-12-05       Impact factor: 4.016

5.  Impact of chronic unpredicted mild stress-induced depression on repaglinide fate via glucocorticoid signaling pathway.

Authors:  Hongyan Wei; Ting Zhou; Boyu Tan; Lei Zhang; Mingming Li; Zhijun Xiao; Feng Xu
Journal:  Oncotarget       Date:  2017-07-04

6.  Optimism as a protective factor against the psychological impact of COVID-19 pandemic through its effects on perceived stress and infection stress anticipation.

Authors:  Sara Puig-Perez; Irene Cano-López; Paula Martínez; Malgorzata W Kozusznik; Adrian Alacreu-Crespo; Matias M Pulopulos; Aranzazu Duque; Mercedes Almela; Marta Aliño; María J Garcia-Rubio; Anita Pollak; Barbara Kożusznik
Journal:  Curr Psychol       Date:  2022-03-16

7.  iTRAQ-based quantitative proteomic analysis provides insight for molecular mechanism of neuroticism.

Authors:  Lei Tian; Hong-Zhao You; Hao Wu; Yu Wei; Min Zheng; Lei He; Jin-Ying Liu; Shu-Zhen Guo; Yan Zhao; Ren-Lai Zhou; Xingang Hu
Journal:  Clin Proteomics       Date:  2019-11-08       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.